US-listed company Basel Medical Group has suspended its Bitcoin acquisition strategy
According to ChainCatcher, as reported by Cointelegraph, US-listed company Basel Medical Group Ltd announced today that it has suspended its Bitcoin acquisition strategy, citing ongoing regulatory uncertainty surrounding digital assets in the United States.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
France's new car registrations in February fell by 14.7% year-on-year
Data: If ETH falls below $1,863, the cumulative long liquidation intensity on major CEXs will reach $709 millions
An address lost $2.33 million by shorting gold and silver.
The United States is not considering releasing strategic oil reserves.
Trending news
MoreCrypto prices
More
